Clinical Trials Update: June 27, 2007
|
TOOLBOX
   Resize
COMMENT
 Discussion Policy
 CLOSE
Comments that include profanity or personal attacks or other inappropriate comments or material will be removed from the site. Additionally, entries that are unsigned or contain "signatures" by someone other than the actual author will be removed. Finally, we will take steps to block users who violate any of our posting standards, terms of use or privacy policies or any other policies governing this site. Please review the full rules governing commentaries and discussions. You are fully responsible for the content that you post.
Who's Blogging  |
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
Diabetes Mellitus, Type 2
This study will evaluate the safety and effectiveness of an investigational drug for people with type 2 diabetes. Volunteers 18-75 may qualify who are currently taking a single diabetic medication or have not taken any diabetes medications in the past two months, and have never taken Actos, Avandia, Resulin, or Romozin.
The research site is in Jonesboro, Ark.
More information
Please see http:/
-----
Gout (Hyperuricemia)
This study will compare the investigational drug febuxostat with allopurinol to control gout and high uric acid levels. Candidates 18-85 may be eligible if they have a history of gout, and do not have secondary hyperuricemia, a history of xanthinuria, active peptic ulcer disease, or rheumatoid arthritis.
The research site is in Lexington, Ky.
More information
Please see http:/
![[slate.com logo]](http://media.washingtonpost.com/wp-dyn/content/graphic/2007/09/27/GR2007092701096.GIF)
